Bluejay Diagnostics (BJDX) Research & Development (2022 - 2023)

Historic Research & Development for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to $1.7 million.

  • Bluejay Diagnostics' Research & Development rose 12164.4% to $1.7 million in Q2 2023 from the same period last year, while for Jun 2023 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is 3924.88% down from last year.
  • Bluejay Diagnostics' Research & Development amounted to $1.7 million in Q2 2023, which was up 12164.4% from $1.4 million recorded in Q1 2023.
  • Bluejay Diagnostics' Research & Development's 5-year high stood at $1.7 million during Q2 2023, with a 5-year trough of $694757.0 in Q1 2022.